• Background: Patients undergoing critical care can experience negative outcomes due to a variety of causes such as lack of sleep, prolonged pain, and anxiety. Our goal was to evaluate the feasibility and efficacy of using meditative virtual reality (VR) to improve the hospital experience of intensive care unit (ICU) patients.
Introduction
A patient's stay in the intensive care unit (ICU) is often traumatic. Patients may experience prolonged states of immobility and sedation as part of their treatment that can lead to the development of ICU-acquired weakness (ICUAW) in 25%-100% of patients [1] . Disrupted sleep cycles, long hospital stays, and extended periods of pain put ICU patients at greater risk for delirium-related mortality [2] . After ICU discharge, 50%-70% of patients exhibit persistent cognitive dysfunction, weakness, and post-traumatic symptoms that can contribute to indefinite negative impacts on the patient's finances, daily life, and need for assistance from friends and family [3] .
Many of these ICU related complications are not the direct result of illness, injury, or medical care. In recent years, critical care professionals have raised attention to modifiable aspects of the ICU environment with the aim of improving the patient recovery experience [4] .
Interventions that encouraged early and regular exercise have shown promising results for prevention of ICUAW in critically ill patients [5] . Clinical guidelines for delirium prevention emphasize strategies to orient patients, maximize comfort, minimize pain, control noise and light, and promote good sleep [6] [7] [8] . Although researchers and clinicians are aware of such modifiable risks, there are relatively few feasible strategies for mitigating these risks in the hospital setting given the limited resources available.
We hypothesize that virtual reality (VR) may provide an ideal platform for controlled, scalable, and effective environmental manipulation in the ICU. VR uses immersive stereoscopic video and audio provided by a head-mounted display, which can be used in conjunction with tracking of the user's hands or body to enable interaction [9] . VR has been praised for mitigating some of the common shortcomings of traditional therapies. VR experiences can help users feel safer, more in control, and more comfortable than in-person outpatient therapy due to less reliance on abstract visualization and less need to present stressful real stimuli [10] . Exposure therapy in VR was demonstrated to be as effective as standard in-situ treatment while being perceived as more tolerable by patients [11] . Preoperative exposure to VR relaxation has shown to reduce anxiety and physiological stress measures in child and adult patients [12, 13] . Severe burn victims reported less pain during treatment when VR relaxation was used during wound debridement [14] . Medical therapy with VR has been generally efficacious and accepted by patients across a variety of treatment contexts. It remains important to expand the applications of VR towards feasible improvements to the patient's healthcare experience [15] .
Recommendations for optimal ICU settings encourage early exercise, comfortable room ambiance, pain management, and good sleep. In addition to the environmental adjustments provided by the healthcare team, VR may provide a system in which some of these recommendations can be enhanced. The purpose of this interdisciplinary study was to evaluate initial feasibility of VR for the relaxation of ICU patients.
Materials and Method

Participants and Setting
This study was conducted on a single-center cohort of patients admitted to the surgical or trauma ICU at University of Florida Health Shands Hospital, a large academic quaternary care facility in the Southeastern United States. All patients at the time of enrollment signed a written consent and were ≥18 years, tested negative for delirium using the Confusion Assessment Method (CAM-ICU), were not in contact isolation (e.g., at high risk of infection or contagious), were likely to stay in the ICU for several days (as reported by the bedside nurse), were not intubated, and did not have any conditions which might limit face, head, or neck movement. The study was approved by the University of Florida Institutional Review Board (#IRB201703107).
Materials
The Google Daydream VR system (vr.google.com/daydream) was used in this study. The VR system consisted of the Google Daydream headset with a hand-held controller and a smartphone inserted into the headset to run VR applications (Figure 1(A) ). The headset with smartphone was lightweight (less than 1 pound) and simple to adjust for fit and comfort. We used Google Spotlight Stories' Pearl (atap.google.com/spotlight-stories) as an initial orientation to VR and RelaxVR (www.relaxvr.co; Figure 1 (B)) to provide patients with a calm immersive scene (e.g., beach with rolling waves) and voiced meditation instructions that promoted breath control and progressive relaxation. In addition to the VR headset, patients were provided with wireless Bluetooth earphones to provide the audio for the VR experience and reduce environmental noise. Both the headset and the earphones were affixed with protective sanitary covers. The headset, smartphone, controller, VR applications, and earphones were collectively referred to as the Digital Rehabilitation Environment Augmenting Medical System (DREAMS). 
Dependent Measures
The primary dependent measures of this study were patients' pain, sleep quality, affect, delirium status, and qualitative responses to using the DREAMS. Pain was measured with the Defense and Veteran's Pain Rating Scale (DVPRS) [16] , sleep quality with the RichardsCampbell Sleep Questionnaire (RCSQ) [17] , affect with the Hospital Anxiety and Depression Scale (HADS) [18] , delirium status with the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) [19] , and patients' qualitative responses to the DREAMS with structured interviews (Supplement A). Each patient's heart rate, respiration rate, and medication logs were retrieved to track if VR had effects on physiology and pain.
The CAM-ICU, DVPRS, heart rate, respiratory rate, blood pressure, and medication logs were recorded by healthcare staff during normal hospital treatment. These data were later retrieved from the University of Florida Integrated Data Repository after sessions were concluded. The RCSQ, HADS, and DREAMS questionnaires were administered by the researchers during sessions.
Session Procedures
The initial session began upon the patient's agreement to participate and signature of the Participants received up to seven sessions in total. Each session occurred at least 24 hours after the previous session. Pearl was only shown during the initial session, and each subsequent session occurred in an otherwise identical manner.
Data Analysis
Results were summarized as frequencies and percentages for categorical variables, mean and standard deviation for normally distributed variables, and median and interquartile ranges for non-normal continuous variables. Paired t-tests with adjustments made for multiple comparisons were used to compare pre-and post-session numerical values. Mixed models were constructed to examine the changes in pain levels (DVPRS), heart rate, respiratory rate, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, opioid medication dosage, 'pro re nata' (PRN) opioid medication dosage, PRN opioid medication frequency, RCSQ, and HADS across study days taking the correlation within the same subject measurements into account. As a sensitivity analysis for measures collected multiple times per day, we constructed models comparing pre-and post-DREAMS session values within one, two, four, six, eight, and twelve hours of the DREAMS session. Dosages of opioids were converted to oral morphine milligram equivalents prior to analysis. Medications received during an operation were excluded from the analysis. Statistical features were extracted from time series physiological data including min, max, variance, and mean across study days for all time intervals. All significance tests were two-sided with α < 0.05 considered statistically significant. Statistical analyses were performed with R v.3.6.
Results
Participants
A total of 59 participants were recruited ( Figure 2 ). Of these 59, 13 participants did not complete the study due to unplanned schedule changes such as emergency surgery or discharge from the ICU. The remaining 46 participants received either one DREAMS session (N = 17), two DREAMS sessions (17) or three to seven DREAMS sessions (N = 12). Participants in general were older adults (M = 50 years, SD = 18) and male (65%) ( Table 1) .
Most participants (61%) were hospitalized emergently. The median hospital stay for all participants was 11 days (25 th : 7,75 th : 23). Interestingly, despite patients reporting no statistically significant improvement in DVPRS before and after each session, 81% of patients agreed or strongly agreed with the statement, "I feel that I experienced less pain yesterday because of the DREAMS" (Figure 4 ).
This discrepancy between patients' objective (i.e., DVPRS) and subjective (i.e., DREAMS questionnaires) pain ratings could be due to confirmation bias, demand characteristics, or subtle effects of VR not identified in this study. Further investigation is required to examine the discrepancy between DVPRS and patient responses to the study questions. The dosage and frequency of opioid medications decreased over time at a rate of 12.9
(95% CI 21.7, 4.03) oral morphine milligram equivalents (MMEs) per study day. No statistically significant changes were found when comparing dosage or frequency before and after any intervention. Nonetheless, the observed decreases in PRN opioid medication dosages comparing the preceding and proceeding 24 hours may be considered clinically significant with an average decrease in PRN opioid dose ranging from 54.8 MME after the first intervention to an average decrease of 11.5 MME after the third intervention (Table 2) . (Figure 5 ), however there was no statistically significant difference observed when comparing successive nights sleep or baseline sleep quality to a given study day. 
Delirium
The Confusion Assessment Method for ICU (CAM-ICU) was used to determine whether patients were delirious. All CAM-ICU scores were retrieved from electronic medical record data for each subject for the duration of their admission. Out of the 46 subjects that participated in a DREAMS session, 13 of them were delirious (as indicated by the patient's chart for at least one day during their admission). Seven of these patients were delirious for at least one day prior to the study but had recovered prior to enrollment in the study. The other six patients were delirious after completing the DREAMS study. Of the six patients that developed delirium after participating in a DREAMS session, the average time between their final DREAMS session and delirium diagnosis was 84 hours. The average duration of these patients' delirium post-study was 140 hours. None of the patients that were delirious prior to participating in the study became delirious after participating in the study.
Vital signs
Patients' blood pressure (BP), heart rate (HR), and respiratory rate (RR) were compared at one, two, four, six, eight, and twelve hours before and after each DREAMS session. No statistically significant differences were observed in pre-vs post-session, minimum, maximum, mean, or variability in systolic BP, diastolic BP, mean arterial pressure, HR, or RR at any time interval or session number.
Participants' Reactions to the DREAMS
Participants were asked to rate how much they agreed with statements about their use of DREAMS and to elaborate on their ratings. Participants generally liked the DREAMS. They agreed with statements about whether the DREAMS was comfortable to interact with (Comfort), they enjoyed the use of the DREAMS (Enjoyment), the DREAMS helped them better manage their pain symptoms (Pain), and they thought about the DREAMS outside of our sessions (Reflection). However, participants were more mixed on whether DREAMS helped them sleep better (Sleep) (Figure 7) . Transcripts of audio recordings were analyzed qualitatively to identify themes in participants' responses. Several key themes emerged. Figure 7 . Participants' reaction to the DREAMS. Comfort = "I thought using the DREAMS was comfortable," Enjoyment = "I liked the experience of using the DREAMS," Pain = "I feel that I experienced less pain yesterday because of the DREAMS," Reflection = "I found myself thinking about the DREAMS after the session was over," Sleep = "I feel that I slept better last night because of the DREAMS." The primary goal of this study was to assess feasibility of VR for ICU patients'
experience. While we did not find clinically or statistically significant effects in health outcomes such as pain management, heart rate, blood pressure, or sleep quality, it should be noted that participants in our study only received 5-20 minutes of VR exposure each day and acute changes in vital signs during and after the VR experience may not have been adequately captured due to the limited granularity of vital signs data provided by the integrated data repository. It seems unlikely that 5-20 minutes of VR exposure would produce large effects on health outcomes in a critical care environment, but this will be an important topic to evaluate empirically in future research. Previous research using VR for inpatient therapy has shown that upwards of 40 minutes of VR for as long as 3 months can be feasibly implemented with good results [15] . There remains good reason to hypothesize that VR exposure can help patients better manage stress and discomfort in environments like the ICU [20] .
Participants in this study may represent selection bias. We approached ICU patients who were conscious, not intubated, not in isolation, and not already delirious. While VR would not be helpful for the unconscious or severely delirious, ICU patients who are otherwise awake should be included in future research as they are at the greatest risk for developing ICUAW and delirium. It will be important for researchers, clinicians, developers, and ICU survivors to collaborate in the design of VR equipment and software tailored for the ICU patient experience-including those who may be immobile, intubated, or in contact isolation.
Patients in the ICU are likely to experience unease and uncertainty in their recovery.
These patients are under constant observation and receive the best medical care available.
However, the vast majority of their time in the ICU is spent in prolonged discomfort and sedentary in an austere environment. VR technologies are relatively affordable, increasingly easy to use, and enjoyed by patients. Therapies in VR can be designed specifically for the needs of patients in the ICU to help them regain or maintain bodily control, improve stress and pain management, and provide a welcomed distraction from unpleasant but necessary medical conditions.
Conclusion
A virtual reality meditative intervention was found to improve patient's experiences in the ICU by reducing patients' levels of anxiety and depression; however, there was no evidence suggesting that VR had any significant effects on physiological measures, pain, or sleep. The use of VR technology in the ICU was shown to be easily implemented and well-received by patients.
The DREAMS project demonstrates that interdisciplinary teams of medical researchers, artists, engineers, and psychologists can and should collaborate with emerging technologies to improve the ICU patient's experience.
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